Transmission dosimetry via MAPS-based event discrimination in a medical linear accelerator by Richard, Hugtenburg
 Cronfa -  Swansea University Open Access Repository
   
_____________________________________________________________
   
This is an author produced version of a paper published in :
X-Ray Spectrometry
                                    
   
Cronfa URL for this paper:
http://cronfa.swan.ac.uk/Record/cronfa20910
_____________________________________________________________
 
Paper:
Hugtenburg, R., Piastopoulou, E., Hancock, L., Page, R. & Velthuis, J. (2015).  Transmission dosimetry via MAPS-
based event discrimination in a medical linear accelerator. X-Ray Spectrometry, 44(4), 239-242.
http://dx.doi.org/10.1002/xrs.2612
 
 
 
 
 
 
 
 
_____________________________________________________________
  
This article is brought to you by Swansea University. Any person downloading material is agreeing to abide by the
terms of the repository licence. Authors are personally responsible for adhering to publisher restrictions or conditions.
When uploading content they are required to comply with their publisher agreement and the SHERPA RoMEO
database to judge whether or not it is copyright safe to add this version of the paper to this repository. 
http://www.swansea.ac.uk/iss/researchsupport/cronfa-support/ 
 Transmission Dosimetry via MAPS-based Event 
Discrimination in a Therapeutic LINAC
R.P. Hugtenburg1,2, E. Piastopoulou1, L. Hancock3, R. Page3 and J.J. Velthuis3
(1) College of Medicine, Swansea University, Singleton Park, SA2 8PP, Swansea, U.K.
(2) Department of Medical Physics and Clinical Engineering, Abertawe Bro Morgannwg  
University Health Board, SA2 8QA, Swansea, U.K.
(3) H.H. Wills Physics Laboratory, University of Bristol, BS8 1TL, Bristol, U.K.
Abstract
Transmission  dosimetry,  which  places  detectors  upstream  of  the  patient  is  a  promising 
method  of  dosimetry  for  intensity  modulated  radiotherapy  (IMRT).  Dose  predicted 
downstream  of  the  patient  is  affected  by  attenuation  and  scattering,  and  changes  in  the 
radiation  field  are  difficult  to  separate  from  changes  in  the  beam  that  might  indicate  a 
erroneous treatment. Monolithic active pixel sensor (MAPS) technology offers a potentially 
cost-effective  method  for  measuring  the  beam profile  in  a  transmission  geometry,  where 
MAPS detectors can be made very thin (interacting with less than 1% of photons), while 
offering  high  spatial  and  temporal  resolution,  and  therefore  event  shape  and  energy 
discrimination to identify the therapeutic component of the beam. This study examines event 
discrimination  in  the  high  dose-rate  environment  associated  with  therapeutic  linear 
accelerators as a method of distinguishing these components. Monte Carlo modelling of the 
LINAC and MAPS detector have been used to predict the spectrum of events in the panel, 
including an evaluation of the occupancy associated with individual LINAC pulses, occurring 
at rates of up to 40 Hz. It is shown via modelling and experimental measurements that there is 
sufficiently  low  occupancy  to  allow  event  discrimination,  and  that  there  are  identifiable 
signatures  associated  with  the  interactions  of  high-energy  therapeutic  photons  versus 
contaminant components traversing the detector.
Introduction
In  recent  years  there  has  been a  dramatic  increase  in  the  uptake  of  intensity-modulated 
radiotherapy (IMRT) in the UK, and globally. There has also been an associated increase in 
the number and complexity of radiation fields used, as confidence in the practice has grown. 
Conventional approaches to treatment verification, such as the use of dosimeters placed on the 
patient, have become a less effective as a means of in vivo dosimetry. Subsequently there has 
been a reduction in the use of in-vivo dosimetry at many centers, exposing patients to the risk 
of mistreatment and the potential for wrongly performed treatments to go undetected.
Transit, or portal, dosimetry, where the dose to the patient is predicted from the downstream, 
portal image, of the radiation source, has recently been adopted at a number of centers, most 
particular NKI in Amsterdam where data from the technique showed that approximately 1 in 
250 treatments had significant errors [1]. With portal imaging the effects of attenuation and 
scattering of radiation in the patient are difficult to separate from changes in the beam, leading 
to a high false-positive rate,  and the potential  obscuration of errors of delivery in certain 
circumstances.
Transmission  dosimetry  which  places  a  thin detector  system upstream of  the  patient  is  a 
promising alternative, but unless the detector is thin enough, the presence of the detector can 
affect the quality of the radiation beam. In megavoltage dosimetry, build-up material, of the 
order of several cm thickness of water-equivalent material,  is generally needed to provide 
charged-particle  equilibrium in order to predict  dose at  depth in the patient.  Furthermore, 
megavoltage  photons produce contaminating  charged particles,  electrons  and positrons,  in 
addition to the penetrating, therapeutic photons. Build-up also serves to mitigate the effect of 
these contaminating charged particles.
Thus  far,  commercially  available  systems [2-4]  using  a  variety  of  dosimetry  systems,  all 
employ significant amounts of build-up, reporting attenuation of the order of several mm of 
plastic material. An alternative approach is the use of monolithic active pixel sensor (MAPS) 
technology, which offers a potentially cost-effective method for measuring the beam profile 
in a transmission geometry, but also offers avenues for predicting dose in the absence of, or 
with  limited  charged-particle-equilibrium,  and  in  presence  of  non-therapeutic,  charged-
particle contamination. In particular, MAPS detectors can be made very thin (interacting with 
less than 1% of photons), while offering high spatial and temporal resolution, and therefore a 
means to identify the therapeutic component of the beam. Recent work has shown that MAPS 
detectors can resolve the sharp penumbrae associated with high-energy photons [5], which 
enables  the accurate  determination  of  the  arrangement  of  the multileaf  collimator  (MLC) 
system in real-time [6], while ongoing studies predict the dose to the patient via Monte Carlo 
modelling  and  subtraction  of  the  diffuse,  contaminating  contributions  in  the  beam.  Such 
detectors are still somewhat limited in their size, the typical radiotherapy field being up to 
40x40 cm2 at 100 cm from the target. The detector is placed closer to the target reducing this 
requirement  somewhat,  particular  compared to transit  dosimetry solutions,  3-side buttable, 
large-scale detectors currently being described [7].
In  this  work  we  examine  the  potential  of  a  MAPS  detector  system  for  the  use  of  the 
spectroscopic  capability,  i.e.  event-shape  and  energy  discrimination,  in  order  to  correctly 
determine the photon fluence, while excluding the effect of contaminating beam components. 
There are several challenging aspects to this  approach, in particular  the therapeutic  linear 
accelerators typically deliver dose-rates in excess of 100 mGy/sec, with a pulse-rate of 400-
600  Hz  and  a  pulse-structure  on  the  scale  on  microseconds.  This  means  that,  although 
extremely fast shuttering systems are now being described [8], data through-put, storage and 
analysis on the scale of GB per-second may ultimately be required.  
Methodology
Calculations  and  measurements  were  performed  for  the  Achilles  MAPS  system  used  in 
previous studies [5,6]. The device consists of a 4096 x 4096 pixel array of pitch of 14 micron 
and an active area of 5.73 x 5.73 cm2. The detector is positioned at a point 55 cm from the X-
ray target and therefore projects to cover a field of approximately 10x10 cm2 at the patient 
plane (100 cm from target), which would however only encompasses a fraction of standard 
radiotherapy treatments. The Achilles can theoretically operate at a frame-rates of up to 100 
Hz,  however  in  order  to  obtain  single-pulse  data,  the  beam  would  need  to  operate  at 
approximately a quarter of the usual dose-rate used in clinical practice. 
Monte Carlo modelling is an established method for determining the spectrum of particles 
generated by the LINAC. The Monte Carlo code BEAMnrc [9] has been used to create lists of 
the properties of the particles, or  phase-space data, leaving the LINAC due to a single pulse 
of  radiation.  By  calculating  the  energy  deposition  in  a  regular  phantom  for  standard 
dosimetric conditions, the conversion between the number of electrons hitting the target in a 
single pulse was determined to be 8x1011 electrons. 
As it is not feasible to run an completely analogue calculation for this number of histories and 
a variance reduction method, uniform bremsstrahlung splitting was used to reduce the number 
of source electrons by a factor of 1000. In this mode, whenever a bremsstrahlung event is 
determined to occur, the outgoing photon is resampled with a new energy and trajectory. The 
resampling procedure has the effect of ensuring that the photons will not strike the detector at 
the same point and the variance reduction reduces the simulation time by approximately a 
factor of 40. The calculation was performed on a supercomputing cluster (HPC Wales), taking 
a total of 200 cpu-hours to complete. Faster methods of calculation could be envisaged, but 
the method of calculation has the advantage of making no prior assumptions about the profiles 
of photons and electrons.
The particles  obtained as phase-space data  were then  transported through a model  of the 
detector system using the DOSXYZnrc code that has an efficient coding system for voxel 
geometries. The energy deposition for a single pulse was subsequently analysed, separating 
therapeutic photons from contaminating charged particles, in order to evaluate the capability 
of the detector to discriminate between the particles on a basis of the energy deposition and 
simple modes of clustering.
The Monte Carlo model employed in the calculations uses a 3x4096x4096 lattice to represent 
the detector. In particular the light-tight rendering with 12 micron layer of Al, the 2 micron 
dead-layer,  and the 12 micron epitaxial  (active)  layer  are  included in  the  model.  The 86 
micron  bulk  layer  was  not  included  in  the  simulations  to  improve  the  efficiency,  as 
backscattering  from  the  bulk  into  the  epitaxial  layer  was  shown  not  to  be  significant 
contributor to events.
Energy deposition was recorded in the lower epitaxial layer. As many events involve particles 
crossing from one pixel into a neighbouring pixel, a simple algorithm was devised to establish 
whether a pixel was isolated (i.e. surrounded by pixels with zero energy deposition), and if 
not, to exclude the event or sum the energy of the neighbouring pixels into the event.
Experimental  studies  were  performed  exposing  the  detector  system  to  55Fe  and  90Sr/90Y 
sources, in order to achieve an approximate calibration of the detector and to understand and 
apply corrections for instrumental broadening. The sources generate clear features that are in 
a  comparable  energy  range  to  the  predominant  modes  of  interaction  associated  with  the 
megavoltage  X-ray  beam,  which  is  the  formation  and  traversal  of  the  detector  by  fast 
electrons. 
Figure 1 and 2 show the spectra recorded for  55Fe and  90Sr, respectively. For  55Fe, K-alpha 
emission at 5.9 and K-beta emission at 6.5 keV produce a single peak at an ADC unit value of 
65 with an FWHM of 35, and can be considered to be approximately monoenergetic. The 
predominant emission from 90Sr/90Y are beta rays with a maximum of 2.28 MeV and therefore 
exhibits a peak associated with the Landau minimum or minimal ionising density threshold of 
the  particles  at  41  ADC,  with  a  FWHM  of  23.  Assuming  linearity  the  peak  position 
corresponds to an energy of 3.7 keV. The Landau minimum in the stopping power is 349.5 
eV/micron  for  electrons  and  positrons  in  silicon,  occuring  at  a  kinetic  energy  of 
approximately  1.25  MeV,  and  corresponds  to  the  deposition  of  4.2  keV for  the  particle 
traversing a 12 micron sensitive layer.
Figure 1. Spectrum obtained with the Achilles MAPS system for 55Fe photon source with principal emission at 
5.9 keV corresponding to K-alpha emission occuring upon disintegration.
   
Figure 2. Spectrum obtained with the Achilles MAPS system for a 90Sr/90Y β- source. The peak occuring at 3.7 
keV is associated with the minimum ionising density threshold for β- particles of kinetic energy, 1.25 MeV. 
The Monte Carlo modelling was compared to measurements performed with the Achilles on a 
SL15  linear  accelerator  running  at  low  dose-rate  of  10  MU/minute.  20  Frames  were 
accumulated and spectra were generated from pixels lying within the open-field field, and 
outside the field,  and therefore exposed to  a  much lower radiation  intensity,  shown from 
previous studies to consist predominately of contaminating electrons.  
Results
Figure 3 shows the Monte Carlo calculated event spectra for photon and photon and electron 
components combined from a single pulse from a 6 MV Elekta Precis LINAC, extracted from 
the central portion of a 5x5 cm2 beam. The occupancy, i.e. the fraction of pixels with energy 
deposition, was found to be appropriately 24%, therefore there was a small but observable 
probability  of multiple  events occurring in some pixels.  The spectra  were broadened to a 
resolution of ΔE = 1.35 keV (FWHM of 3.2 keV) obtained for the 55Fe exposures, including 
adding pixels found to have zero energy deposition,  utilising comparable spread; noise in 
empty pixels can be assumed to be comparable in resolution to monoenergetic features at the 
low-energy limit  of the detector.  Using the simplistic clustering algorithm, 9.5% of pixels 
were able to be identified as non-coalesced events in the central  1833x1833 region of the 
detector corresponding to uniform field of the 5x5 field, while 37% of pixels were found to be 
empty. The clustering method is satisfactory for Monte Carlo generated data, however the 
model is somewhat limited in that stochastic noise will be present in empty pixels and does 
not  include the effect  of  charge sharing,  which has the effect  of smearing events  across 
neighbouring pixels.
Figure 3.  Monte Carlo calculated spectra  for  all  particles  (upper solid line)  and and contaminating charged 
particle  component (lower solid line)  for a single pulse from a therapeutic  linac consisting of 8x10 11 initial 
electrons  at  the  target.  The spectra  were  smoothed  with a  Gaussian  of   ΔE = 1.35 keV,  derived  from the 
measurements in the 55Fe 5.9 keV source. Noise was added to pixels containing zero energy to simulate the effect 
of stochastic noise in the detector and the figure is offset to show this effect below the mean pedestal value. 
In the spectra it can be seen that photons are dominate the energy deposition at both low-
energy  and  high-energy  limits,  the  former  associated  with  Compton  electrons  or  pair 
production  interactions  occuring  in  the  detector  active  volume,  the  latter  associated  with 
interactions occuring in the light-tight and dead layers, generating high-angle electrons and 
positrons, compared with contaminant charged-particles that are generated further upstream. 
Figure 4 shows the spectrum obtained from the Achilles detector in the central (open-field) 
portion of the beam versus the spectrum obtained for regions outside of the beam. Standard 
procedures are used for the analyse, that include dead-pixel, dark-field pedestal removal and 
sophisticated  event-clustering  techniques.  Such  methods  are  challenging  at  the  level  of 
occupancy associated with single pulses, and as a consequence the spectra are not as feature-
rich as those obtained by Monte Carlo, and predicted at the resolution suggested by low dose-
rate sources. In particular charge-sharing between pixels is the predominant effect associated 
with the loss of resolution at such high occupancy. The differences between the spectra do 
however appear to follow the overall changes in shape of the spectra obtained from Monte 
Carlo expected for photon and electron dominated regions.
Figure 4.  Spectra  measured  with the Achilles  MAPS system for  a  series  of 20 pulses from a Elekta SL15  
therapeutic  linear  accelerator  operating  at  10  MU s-1,  a  sufficiently  low dose-rate  to  enable  pulse-by-pulse 
recovery by the device.  The open field contains a mixture of photons and contaminating charged particles, while 
the outside of the field contains predominantly the contaminant radiation due to scattering processes in the head 
an intervening air.
Conclusions
It has been shown that there is, in principle, a sufficiently low occupancy associated with a 
single LINAC pulse to allow event discrimination and that there are identifiable signatures 
associated with the interactions of high energy therapeutic photons in the panel that can assist 
in  discriminating  the  therapeutic  component  from contaminating  components,  principally 
electrons generated in the head and intervening air.
The high dose associated with a single pulse is a challenging environment for the detector 
with occupancy at a sufficiently high to level to observe loss of resolution due to difficulties 
in  applying  clustering  algorithms  due  to  the  effects  of  charge  sharing  between  pixels. 
Although the Achilles  MAP is able to operate  at  100 Hz, this  is  not sufficiently  rapid to 
handle  pulse-rates  of  400  Hz  or  more  typically  used  in  radiotherapy  treatments.  A  new 
generation of MAPS detectors promise MHz frame-rates [8] may solve these issues in the 
near future.
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